FibroBiologics, Inc. Common Stock
FBLGFibroBiologics, Inc. (FBLG) is a biotechnology company focused on the development and commercialization of regenerative medicine products derived from human fibroblast cells. The company primarily aims to create innovative therapies for wound healing, tissue repair, and other medical applications by leveraging its proprietary cell-based technology platforms.
Company News
FibroBiologics, a clinical-stage biotechnology company, closed a $4 million registered direct offering by issuing common stock and pre-funded warrants to an existing shareholder, with proceeds intended for general corporate purposes and debt satisfaction.
FibroBiologics completed a $4 million registered direct offering by selling common stock and pre-funded warrants to an existing shareholder, with the purchase price paid in gold coins. The company intends to use proceeds for general corporate purposes and debt satisfaction.
